Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000008870 | SCV001135923 | pathogenic | Familial acute necrotizing encephalopathy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000008870 | SCV002296791 | uncertain significance | Familial acute necrotizing encephalopathy | 2023-09-30 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 656 of the RANBP2 protein (p.Ile656Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with acute necrotizing encephalopathy (PMID: 19118815, 22030434). This variant is also known as c.2094A>G, g.33868A>G. ClinVar contains an entry for this variant (Variation ID: 8365). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV000008870 | SCV005049751 | likely pathogenic | Familial acute necrotizing encephalopathy | 2024-03-15 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000008870 | SCV000029080 | risk factor | Familial acute necrotizing encephalopathy | 2009-01-01 | no assertion criteria provided | literature only | |
Gene |
RCV000008870 | SCV000212037 | not provided | Familial acute necrotizing encephalopathy | no assertion provided | literature only |